article thumbnail

Rethinking mechanical heart valves in the aortic position: new paradigms in design and testing

Frontiers in Cardiovascular Medicine

Bileaflet mechanical heart valves (MHV) remain a viable option for aortic valve replacement, particularly for younger patients and patients from low- and middle-income countries and underserved communities. Despite their exceptional durability, MHV recipients are at increased risk of thromboembolic complications.

article thumbnail

Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery

DAIC

Michael Rinaldi , an interventional cardiologist and the medical director of the structural heart program at Atrium Health Sanger Heart & Vascular Institute. "We We have been eagerly anticipating the opportunity to bring this innovative technology to our community.

article thumbnail

Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review

The British Journal of Cardiology

In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment. It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials.

article thumbnail

Heart Valve Disease Forum 2023

Society of Thoracic Surgeons - Allied Health

This year, session topics will explore academic and systematic considerations on the basics of the aortic valve to the latest trends, various surgical methods, and treatments employing experts from various fields. There will also be an in-depth discussion on the lifelong management of aortic valve surgery patients.

article thumbnail

Autus Valve | The expandable artificial heart valve

Wellnest

In such scenarios, cardiologists’ primary form of treatment for children with coronary heart disease is a heart valve implant. Unfortunately, the traditional pulmonary valves have a fixed diameter that can’t match the size of the child’s heart over time.

article thumbnail

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

DAIC

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Owing to high mortality risk, access to open heart surgery is severely restricted and is not considered an option for most patients with TR.

article thumbnail

Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial

DAIC

Getty Images milla1cf Thu, 01/04/2024 - 11:04 January 4, 2024 — Laguna Tech USA , a privately-held medical technology company dedicated to innovations in structural heart solutions to broaden useability and applicability for patients, today announced that a record number five patients were successfully treated at a single center on the same day with (..)